Sarepta Therapeutics | Attività

Assets Cambiamento Data
Acadia Pharmaceuticals USD 748.96M 116.42M 2023-12
Agios Pharmaceuticals USD 937.12M 70.14M 2023-12
Alnylam Pharmaceuticals USD 3.83B 9.19M 2023-12
Amgen USD 97.15B 6.62B 2023-12
Avrobio USD 110.52M 23.31M 2023-09
Daiichi Sankyo JPY 2.65T 33.03B 2023-09
Eli Lilly USD 57.92B 3.1B 2023-09
Gilead Sciences USD 62.13B 248M 2023-12
Incyte USD 6.78B 393.87M 2023-12
Insmed USD 1.33B 4.96M 2023-12
Ionis Pharmaceuticals USD 2.99B 56.1M 2023-12
Moderna USD 18.43B 1.02B 2023-12
Neurocrine Biosciences USD 2.85B 235.1M 2023-09
Pfizer USD 215.02B 5.15B 2023-09
PTC Therapeutics USD 1.9B 635.81M 2023-12
Regeneron Pharmaceuticals USD 33.08B 916.9M 2023-12
Roche Holding CHF 84.37B 3.78B 2023-06
Sarepta Therapeutics USD 3.11B 16.18M 2023-09
Ultragenyx Pharmaceutical USD 1.49B 252.87M 2023-12
Vertex Pharmaceuticals USD 21.73B 1.38B 2023-09



Sarepta Therapeutics Attività - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.